论文信息 - A Phase II Study of Double Immune Checkpoint Inhibitor Blockade with Nivolumab and Ipilimumab with or without Azacitidine in Patients with Myelodysplastic Syndrome (MDS) - 字舞流文

A Phase II Study of Double Immune Checkpoint Inhibitor Blockade with Nivolumab and Ipilimumab with or without Azacitidine in Patients with Myelodysplastic Syndrome (MDS)

M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | N. Pemmaraju | Kiyomi Morita | Y. Alvarado | K. Sasaki | P. Bose | K. Naqvi | C. Rausch | K. Chien | G. Bravo | Yvonne Gasior